Malignant ascites

Hyperthermic Intraperitoneal Perfusion Chemotherapy and Cytoreductive Surgery for Controlling Malignant Ascites From Ovarian Cancer
Mingchen Ba, Hui Long, Xiangliang Zhang, Yunqiang Tang, Yinbing Wu, Shuai Wang, Zhaofei Yan, Bohuo Zhang, Shuzhong Cui

International Journal of Gynecologic Cancer Nov 2016, 26 (9) 1571-1579; DOI: 10.1097/IGC.0000000000000809
Potential Significance of Peptidome in Human Ovarian Cancer for Patients With Ascites
Xiaohao Huang, Juan Zhou, Ranran Tang, Suping Han, Xue Zhou

International Journal of Gynecologic Cancer Feb 2018, 28 (2) 355-362; DOI: 10.1097/IGC.0000000000001166
Catumaxomab for the Treatment of Malignant Ascites in Patients With Chemotherapy-Refractory Ovarian Cancer: A Phase II Study
Jonathan S. Berek, Robert P. Edwards, Lynn P. Parker, Leslie R. DeMars, Thomas J. Herzog, Samuel S. Lentz, Robert T. Morris, Wallace L. Akerley, Robert W. Holloway, Michael W. Method, Steven C. Plaxe, Joan L. Walker, Hilke Friccius-Quecke, Carolyn N. Krasner

International Journal of Gynecologic Cancer Nov 2014, 24 (9) 1583-1589; DOI: 10.1097/IGC.0000000000000286

Main menu